Brian Freeman/LinkedIn
Aug 21, 2026, 08:32
Brian Freeman: Supporting Innovation in Rare Blood Disorders
Brian Freeman, Sr Manager, Leadership Search and Scouting at Sanofi, shared a post on LinkedIn:
“While a rare blood disorder diagnosis can reshape the path ahead, it doesn’t define what’s possible.
At Sanofi, we’re committed to advancing research and supporting scientific innovation to help create more possibilities for the rare blood disorders community.
This starts with listening to people living with hemophilia and immune thrombocytopenia (ITP) to understand their unique needs, and using those insights to help shape progress for the rare blood disorders community.
Hear patient perspectives, discover resources, and learn more about rare blood disorders.”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 16:43Beth Shirley: Xylitol Consumption Increases Platelet Reactivity and Cardiovascular Risk
-
Oct 6, 2026, 16:37Jared Rice: What Sets the Transfusion Threshold in Anemia of Prematurity?
-
Oct 6, 2026, 16:30Thirunavukkarasu Angappan: Immunoglobulin Decides How Much Plasma Gets Collected
-
Oct 6, 2026, 16:18Gemma Davies: New CMML Research Selected for Presentation at the 68th ASH Annual Meeting
-
Oct 6, 2026, 16:03Professor Csongor Kiss Receives the Kálmán Laki Prize – Hungarian Society of Thrombosis and Haemostasis
-
Oct 6, 2026, 15:52Mark Kheifets: A Massive Stent Thrombosis Requiring Aspiration Thrombectomy
-
Oct 6, 2026, 15:40Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity
-
Oct 6, 2026, 15:36Nominations Open for ISTH Outstanding Mentor Awards – ISTH
-
Oct 6, 2026, 15:17Walaa Obaid: How Warfarin Went From Poison To Medicine